Clinical Trial

Interventional Study on the Effects of Forest Therapy in Fibromyalgia Patients

Study acronym: ForCare
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate if Forest therapy can reduce pain levels and improve the quality of life related to the level of pain perceived in fibromyalgia patients. The main question it aims to answer is: Does frequenting certified forest environments, according to the principles and methods of Forest Therapy, produce positive effects on chronic pain and the consumption of painkillers? The study is part of the "Forest Therapy Project as a Broad-Spectrum Tool for Patients Affected by Fibromyalgia" funded by the Tuscany Region as part of the Complementary Medicine program for the three-year period 2025-2027. The project will be carried out thanks to the collaboration with the National Research Council - Institute for BioEconomy (CNR-IBE)
Trial Details
NCT Number NCT07648563
Lead Sponsor Azienda USL Toscana Nord Ovest
Conditions Fybromyalgia, Fibromyalgia (FM)
Enrollment 70 participants
Start Date 2026-09-01
Primary Completion 2027-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-15